LATEST UPDATES: New study on ThyroSeq assessing clinical utility and cost-effectiveness in a Public Healthcare setting – SEE ARTICLE HERE

×

ThyroSeq

Cutting-edge molecular testing for

personalized management of patients with

thyroid nodules and cancer

 

Learn More

ThyroSeq® provides clear results for management of thyroid nodules and cancer

  • High diagnostic accuracy

  • High reduction (61-67%) of diagnostic surgeries in nodules with indeterminate cytology

  • Probability of cancer and prediction of cancer recurrence, informing personalized patient management

  • Flexibility in acceptable sample types

ThyroSeq is available for international patients. Please contact us to set up ThyroSeq testing.

Test performance in Bethesda III and IV thyroid nodules based on results of multicenter validation study

News & Updates

New information on ThyroSeq performance in patients from Southeast Asia

Learn about how ThyroSeq v3 informed surgical management in Canadian Public